These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34926252)

  • 1. Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma.
    Kong W; Yang T; Wen X; Mu Z; Zhao C; Han S; Tian J; Zhang X; Zhou T; Zhang Y; Lou F; Cao S; Wang H; Zhang J
    Front Oncol; 2021; 11():737547. PubMed ID: 34926252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma.
    Feng H; Cao S; Ouyang Q; Li H; Li X; Chen K; Zhang X; Huang Y; Zhang X; Ma X
    Transl Androl Urol; 2023 Feb; 12(2):308-319. PubMed ID: 36915884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
    Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
    JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
    Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
    JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
    Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
    Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
    Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
    medRxiv; 2023 Jan; ():. PubMed ID: 36712083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
    Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
    Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late-onset cancers.
    Hao S; Zhao X; Fan Y; Liu Z; Zhang X; Li W; Yuan H; Zhang J; Zhang Y; Ma T; Tao H
    Cancer Med; 2023 Sep; 12(17):18394-18404. PubMed ID: 37610374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
    Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
    Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
    Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
    Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
    Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-ethnic variation in germline variants of patients with renal cell carcinoma.
    Abou Alaiwi S; Nassar AH; Adib E; Groha SM; Akl EW; McGregor BA; Esplin ED; Yang S; Hatchell K; Fusaro V; Nielsen S; Kwiatkowski DJ; Sonpavde GP; Pomerantz M; Garber JE; Freedman ML; Rana HQ; Gusev A; Choueiri TK
    Cell Rep; 2021 Mar; 34(13):108926. PubMed ID: 33789101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
    Gleeson JP; Nikolovski I; Dinatale R; Zucker M; Knezevic A; Patil S; Ged Y; Kotecha RR; Shapnik N; Murray S; Russo P; Coleman J; Lee CH; Stadler ZK; Hakimi AA; Feldman DR; Motzer RJ; Reznik E; Voss MH; Chen YB; Carlo MI
    Clin Cancer Res; 2021 May; 27(10):2910-2919. PubMed ID: 33658299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
    Berchuck JE; Boiarsky D; Silver R; Sunkara R; McClure HM; Tsai HK; Siegmund S; Tewari AK; Nowak JA; Lindeman NI; Rana HQ; Choudhury AD; Pomerantz MM; Freedman ML; Van Allen EM; Taplin ME
    JCO Precis Oncol; 2022 Aug; 6():e2200329. PubMed ID: 36103646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases.
    Yngvadottir B; Andreou A; Bassaganyas L; Larionov A; Cornish AJ; Chubb D; Saunders CN; Smith PS; Zhang H; Cole Y; Research Consortium GE; Larkin J; Browning L; Turajlic S; Litchfield K; Houlston RS; Maher ER
    Hum Mol Genet; 2022 Aug; 31(17):3001-3011. PubMed ID: 35441217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity.
    Smith PS; West H; Whitworth J; Castle B; Sansbury FH; Warren AY; Woodward ER; Tischkowitz M; Maher ER
    Genes Chromosomes Cancer; 2021 Jan; 60(1):5-16. PubMed ID: 32830346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study.
    Arrieta O; Caballé-Pérez E; Hernández-Pedro N; Romero-Nuñez E; Lucio-Lozada J; Castillo-Ruiz C; Acevedo-Castillo K; María Álvarez-Gómez R; Molina-Garay C; Jiménez-Olivares M; Carrillo-Sánchez K; Cristina Mendoza-Caamal E; Cardona AF; Remon J; Alaez-Verson C
    Lung Cancer; 2024 Jun; 194():107864. PubMed ID: 38945003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
    Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
    Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.
    Liu M; Liu X; Suo P; Gong Y; Qu B; Peng X; Xiao W; Li Y; Chen Y; Zeng Z; Lu Y; Huang T; Zhao Y; Liu M; Li L; Chen Y; Zhou Y; Liu G; Yao J; Chen S; Song L
    Transl Lung Cancer Res; 2020 Jun; 9(3):646-658. PubMed ID: 32676327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.